Who invested in Genialis

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2023, from 2 sources

$13MSeries A$700KRound

Latest round: Round, $700KDec 2025
Biggest round: $13MSeries A · Mar 2023
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202320242025

$13MSeries A$700KRound

First round: Series A, $13M
Biggest round: $13M
Between rounds: 2.8 years

The rounds

Dec 2025
Round$700K
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $700K sold, first sale Dec 2025
Mar 2023
Series A$13M3 new
Source recordedSEC filing: $11M sold, first sale Jan 2023

Founders and team

From Genialis's own website: 4 on the team.

Tjaša Krisper KutinChief Operating Officer
Cédric OdjeInvestment Associate
Krista McKerracherChairperson
Paoyen LaiSenior Investment Manager

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2023Round2025

Redalpine

EASME - EU Executive Agency for SMEs

Taiwania Capital

Everyone who backed them

RedalpineVC firm1round

EASME - EU Executive Agency for SMEsGovernment1round

Taiwania CapitalGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Genialis as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.